Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women

Archives of Gynecology and Obstetrics

Volumn 285, Issue 2, 2012, Pages 397-403

  Capobianco, Giampiero ^a   Donolo, Ermes ^a   Borghero, Gianna ^a   Dessole, Francesco ^a   Cherchi, Pier Luigi ^a   Dessole, Salvatore ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Pelvic floor rehabilitation; Postmenopausal women; Recurrent urinary tract infections; Urinary incontinence; Urogenital atrophy; Vaginal estriol

Indexed keywords

ESTRIOL;

ABDOMINAL PRESSURE; ADULT; AGING; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; ELECTROSTIMULATION; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MAXIMAL URETHRAL PRESSURE; MEAN URETHRAL CLOSURE PRESSURE; PELVIC FLOOR MUSCLE TRAINING; POSTMENOPAUSE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; STRESS INCONTINENCE; SYMPTOM; TREATMENT DURATION; URETHRA PRESSURE; URETHROCYSTOMETRY; URINARY TRACT INFECTION; URINE CULTURE; UROGENITAL ATROPHY; UROGENITAL TRACT DISEASE;

ADMINISTRATION, INTRAVAGINAL; AGING; ANALYSIS OF VARIANCE; ATROPHY; DYSPAREUNIA; ELECTRIC STIMULATION THERAPY; ESTRIOL; EXERCISE THERAPY; FEMALE; HUMANS; MIDDLE AGED; PELVIC FLOOR; POSTMENOPAUSE; PRESSURE; URETHRA; URINARY BLADDER; URINARY INCONTINENCE, STRESS; URINARY TRACT INFECTIONS; UROGENITAL SYSTEM; VAGINA;

EID: 84864458446     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-1955-1     Document Type: Article

References (36)

1. Greendale GA, Judd HL (1993) The menopause: health implications and clinical management. J Am Geriatr Soc 41:426-436
2. Cardozo L, Bachmann G, McClish D, Fonda D, Birgenson L (1998) Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the hormones and urogenital therapy committee. Obstet Gynecol 92:722-727
3. Barlow DH, Samsioe G, van Geelen JH (1997) A study of European women's experience of the problems of urogenital ageing and its management. Maturitas 27:239-247
4. Samsioe G (1998) Urogenital aging. A hidden problem. Am J Obstet Gynecol 178:S245-S249
5. Iosif CS, Batra S, Ek A, Astedt B (1981) Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol 141:817-820
6. Smith P (1993) Estrogens and the urogenital tract. Acta Obstet Gynecol Scand 157(suppl):1-25
7. Samsioe G, Jansson I, Mellstrom D, Svanborg A (1985) Occurrence, nature and treatmentofurinary incontinence ina 70-year-old female population. Maturitas 7:335-342
8. Nilsson K, Heimer G (1992) Low-dose oestradiol in the treatment of urogenital oestrogen deficiency: a pharmacokinetic and phar-macodynamic study. Maturitas 15:121-127
9. Smith P, Heimer G, Lindskog M, Ulmsten U (1993) Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy. Maturitas 16:145-154
10. Fantl JA, Cardozo L, McClish DK (1994) Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the hormones and urogenital therapy committee. Obstet Gynecol 83:12-18
11. Dessole S, Rubattu G, Ambrosini G, Gallo O, Capobianco G, Cherchi PL, Marci R, Cosmi E (2004) Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause 11:49-56
12. Esposito G (1991) Estriol: a weak estrogen or a different hormone? Gynecol Endocrinol 5:131-153
13. Heimer GM, Englund DE (1992) Effects of vaginally-adminis-tered oestriol on post-menopausal urogenital disorders: a cyto-hormonal study. Maturitas 14:171-179
14. Iosif CS (1992) Effects of protracted administration of estriol on the lower genito urinary tract in postmenopausal women. Arch Gynecol Obstet 251:115-120
15. Foidart JM, Vervliet J, Buytaert P (1991) Efficacy of sustained-release vaginal oestriol in alleviating urogenital and systemic climacteric complaints. Maturitas 13:99-107
16. Van der Linden MC, Gerretsen G, Brandhorst MS, Ooms EC, Kremer CM, Doesburg WH (1993) The effect of estriol on the cytology of urethra and vagina in postmenopausal women with genito-urinary symptoms. Eur J Obstet Gynecol Reprod Biol 51:29-33
17. Henriksson L, Stjernquist M, Boquist L, Alander U, Selinus I (1994) A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol 171:624-632
18. Bottiglione F, Volpe A, Esposito G, Aloysio DD (1995) Transvaginal estriol administration in postmenopausal women: a double blind comparative study of two different doses. Maturitas 22:227-232
19. Barentsen R, van de Weijer PH, Schram JH (1997) Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol Reprod Biol 71:73-80
20. Dugal R, Hesla K, Sordal T, Aase KH, Lilleeidet O, Wickstrom E (2000) Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. Acta Obstet Gynecol Scand 79:293-297
21. Kanne B, Jenny J (1991) Local administration of low-dose estriol and vital Lactobacillus acidophilus in postmenopause. Gynakol Rundsch 31:7-13
22. Raz R, Stamm WE (1993) A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 329:753-756
23. Dmochowski RR, Miklos JR, Norton PA, Zinner NR, Yalcin I, Bump RC (2004) Duloxetine urinary incontinence study group. Duloxetine versus placebo for the treatment of Noth American women with stress urinary incontinence. J Urol 170:1259-1263
24. Berghmans LCM, Hendrikis HJM, Bo K, Hay-Smith EJ, de Bies RA, van Waalwijk, van Doorn ESC (1998) Conservative treatment if stress urinary incontinence in women: a systematic review of randomized clinical trials. Br J Urol 82:181-189
25. Castro RA, Arruda RM, Zanetti MRD, Santos PD, Sartori MGF, Girao MJBC (2008) Single-blind, randomized, controlled trial of pelvic floor muscle training, electrical stimulation, vaginal cones, and no active treatment in the management of stress urinary incontinence. Clinics 63:465-472
26. Leriche B, Conquy S (2010) Guidelines for rehabilitation management of non-neurological urinary incontinence in women. Prog Urol 20:S104-S108
27. Archer DF (2010) Efficacy and tolerability of local estrogen therapy for urogenital atrophy. Menopause 17:194-203
28. Shumaker SA, Woman JF, Uebersax JS, McClish D, Fantl JA (1994) Health-related quality-of-life measures for women with urinary incontinence-the incontinence impact questionnaire and the urogenital distress inventory. Qual Life Res 3:291-306
29. Mishell DR (1987) Menopause: physiology and pharmacology. Yearbook Medical Publisher, Chicago
30. Wied GL, Bibbo M (1975) Evaluation of endocrinologic condition by exfoliative cytology. In: Gold JJ (ed) Textbook of gynaecologic endocrinology. Harper and Row, New York, pp 117-155
31. Ishiko O, Hirai K, Sumi T, Tatsuta I, Ogita S (2001) Hormone replacement therapy plus pelvic floor muscle exercise for post-menopausal stress incontinence. A randomized, controlled trial. J Reprod Med 46:213-220
32. Schar G, Kochli OR, Fritz M, Heller U (1995) Effect of vaginal estrogen therapy on urinary incontinence in postmenopause. Zentralbl Gynakol 117:77-80
33. Lose G, Englev E (2000) Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. BJOG 107:1029-1034
34. Bhatia NN, Bergman A, Karram MM (1989) Effects of estrogen on urethral function in women with urinary incontinence. Am J Obstet Gynecol 160:176-181
35. Hilton P, Stanton SL (1983) The use of intravaginal estrogen cream in genuine stress incontinence. Br J Obstet Gynaecol 90:940-944
36. Sturdee DW, Panay N, International Menopause Society Writing Group (2010) Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 13:509-522